Healio

‘Significant gaps’ reported in testing, treatment among pregnant people with HCV

Please provide your email address to receive an email when new articles are posted on . Of HCV antibody positive individuals, nearly 23% had their earliest RNA test during a pregnancy. Among nearly ...
Medscape

New Model Reveals Key Predictors of Hepatitis C Virus Transmission From Mother to Child

Maternal hepatitis C virus (HCV) RNA titer > 10⁶ International Units (IU)/mL and antepartum bleeding are key predictors of perinatal transmission, with the risk ranging from 1.5% to 28.5%. The ...
Healio

FDA clears first ‘rapid diagnostic’ hepatitis C RNA test for point-of-care settings

Please provide your email address to receive an email when new articles are posted on . The FDA granted marketing authorization for Cepheid’s Xpert HCV test and GeneXpert Xpress System, the first ...
clinicaladvisor.com

Only a Third of US Adults With Hepatitis C Virus Are Treated

There are persistent gaps in testing-to-treatment linkage and the need for broader access and care coordination among patients with HCV. Only approximately one-third of US adults diagnosed with ...
Monthly Prescribing Reference

FDA Clears Point-of-Care Test to Detect Hepatitis C Virus

Credit: Cepheid. The Xpert HCV test delivers results in about an hour. The Food and Drug Administration (FDA) has granted marketing authorization to Xpert ® HCV, a point-of-care hepatitis C virus (HCV ...
Nasdaq

Atea Pharmaceuticals Announces Positive Initial Data from Phase 2 Study for Hepatitis C Virus (HCV) and Significant Enrollment Milestone for Phase 3 SUNRISE-3 Trial for COVID-19

A 98% Sustained Virologic Response at Week 4 (SVR4) Post-Treatment Observed in Initial Data From 52 Patients in Lead-In Cohort in Phase 2 HCV Study Phase 3 SUNRISE-3 Enrollment Surpassed 650 Patients ...